NTHI (NeOnc Technologies Holdings, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by NTHI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-13 | NASIM SHOMALI | Director | A | — | — |
| 2026-05-04 | Amir F Heshmatpour | President | Buy | — | — |
| 2026-04-28 | Amir F Heshmatpour | President | Buy | — | — |
| 2026-04-24 | Yousha Neman-Ebrahim | Chief Clinical Officer | Buy | — | — |
| 2026-04-24 | KEITHLY GARNETT | CFO | Buy | — | — |
| 2026-04-23 | Amir F Heshmatpour | President | Buy | — | — |
| 2026-04-13 | DAVID JR. SUH | Chief Accounting Officer | MIXED | — | — |
| 2026-04-10 | Amir F Heshmatpour | President | Buy | — | — |
| 2026-04-09 | Amir F Heshmatpour | President | Buy | — | — |
| 2026-04-06 | Amir F Heshmatpour | President | Buy | — | — |
| 2025-11-24 | Yousha Neman-Ebrahim | Chief Clinical Officer | Buy | — | — |
| 2025-11-24 | Amir F Heshmatpour | President | Buy | — | — |
| 2025-11-10 | Amir F Heshmatpour | President | A | — | — |
| 2025-06-09 | Yousha Neman-Ebrahim | Chief Clinical Officer | A | — | — |
| 2025-06-05 | PATRICK WALTERS | COO | MIXED | — | — |
| 2025-06-05 | MING-FU (ALAN) CHIANG | Director | MIXED | — | — |
| 2025-06-05 | THOMAS C CHEN | CEO | MIXED | — | — |
| 2025-06-05 | Amir F Heshmatpour | Director | MIXED | — | — |
| 2025-06-05 | KEITHLY GARNETT | CFO | MIXED | — | — |
| 2025-05-23 | KEITHLY GARNETT | CFO | Buy | — | — |
| 2025-05-23 | Amir F Heshmatpour | President | Buy | — | — |
| 2025-05-23 | THOMAS C CHEN | CEO | Buy | — | — |
| 2025-05-22 | KEITHLY GARNETT | CFO | Buy | — | — |
| 2025-05-22 | KEITHLY GARNETT | CFO | Buy | — | — |
| 2025-05-19 | KEITHLY GARNETT | CFO | Buy | — | — |
| 2025-05-19 | THOMAS C CHEN | CEO | Buy | — | — |
| 2025-05-19 | Jim Delshad | Director | Buy | — | — |
| 2025-05-19 | Amir F Heshmatpour | President | Buy | — | — |
| 2025-04-08 | KEITHLY GARNETT | CFO | MIXED | — | — |
| 2025-04-08 | Amir F Heshmatpour | Director | MIXED | — | — |
| 2025-04-08 | THOMAS C CHEN | CEO | MIXED | — | — |
| 2025-04-08 | PATRICK WALTERS | COO | MIXED | — | — |
| 2025-04-08 | MING-FU (ALAN) CHIANG | Director | MIXED | — | — |
| 2025-03-28 | KEITHLY GARNETT | CFO | J | — | — |
| 2025-03-28 | PATRICK WALTERS | COO | J | — | — |
| 2025-03-28 | Amir F Heshmatpour | Director | J | — | — |
| 2025-03-28 | Jim Delshad | Director | A | — | — |
| 2025-03-28 | MING-FU (ALAN) CHIANG | Director | MIXED | — | — |
| 2025-03-28 | THOMAS C CHEN | CEO | J | — | — |
| 2025-03-28 | STEVEN L. GIANNOTTA | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President | 3,328,120 | — |
| — | COO | 888,220 | — |
| — | Director | 775,842 | — |
| — | CEO | 644,921 | — |
| — | CFO | 285,253 | — |
| — | Chief Clinical Officer | 134,760 | — |
| — | Chief Accounting Officer | 111,866 | — |
| — | Director | 50,260 | — |
| — | Director | 50,160 | — |
| — | Director | 50,160 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NTHI quote page; the site-wide leaderboard is on the insider transactions hub.